Keigo Tsujimoto
Corporate Officer/Principal presso LINICAL CO., LTD.
Patrimonio netto: 3 M $ in data 30/06/2024
Provenienza dei contatti di primo grado di Keigo Tsujimoto
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Miscellaneous Commercial Services | 15 | |
Linical USA, Inc.
 Linical USA, Inc. Miscellaneous Commercial ServicesCommercial Services Linical USA, Inc. provides research services. The company is headquartered in San Diego, CA.
2
| Subsidiary | Miscellaneous Commercial Services | 2 |
Linical Accelovance America, Inc.
2
| Subsidiary | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Keigo Tsujimoto tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| Linical Taiwan Co. Ltd. | Director/Board Member Director/Board Member Chairman President Director/Board Member | ||
Linical Korea Co., Ltd.
 Linical Korea Co., Ltd. BiotechnologyHealth Technology Part of Linical Co., Ltd., Linical Korea Co., Ltd. is a South Korean company that provides contract research organization (CRO) services to pharmaceutical companies. The company is based in Seoul, South Korea. | Biotechnology | Director/Board Member Director/Board Member President | |
| ASTELLAS PHARMA INC. | Pharmaceuticals: Major | Chairman Investor Relations Contact | |
| Linical China Co. Ltd. | Director/Board Member Chairman | ||
Linical Europe Holding GmbH
 Linical Europe Holding GmbH Medical/Nursing ServicesHealth Services Part of Linical Co., Ltd., Linical Europe Holding GmbH operates as a holding German company with interests in pharmaceutical research and development. The company is based in Frankfurt, Germany. The CEO of the company is Isao Sakamoto. Linical Europe Holding was acquired by Linical Co., Ltd. from ADCURAM Invest GmbH on December 01, 2014 for $8.20 million. | Medical/Nursing Services | Chief Executive Officer President | |
| University of Tokyo | College/University | Undergraduate Degree | |
| MITSUI FUDOSAN CO., LTD. | Real Estate Development | Director/Board Member | |
| DAICEL CORPORATION | Chemicals: Specialty | Director/Board Member | |
| Tokyo Metropolitan Public University Corp. | College/University | Undergraduate Degree | |
Nippon Boehringer Ingelheim Co., Ltd.
 Nippon Boehringer Ingelheim Co., Ltd. Pharmaceuticals: MajorHealth Technology Established in 1961, Nippon Boehringer Ingelheim Co., Ltd. develops, manufactures, imports and markets pharmaceutical products. The company is also involved in the importation and exportation of intermediates and bulk pharmaceutical products. Nippon Boehringer Ingelheim is based in Tokyo and operates in several parts of Japan through its domestic offices. | Pharmaceuticals: Major | President | |
Novartis Pharma KK
 Novartis Pharma KK Pharmaceuticals: MajorHealth Technology Novartis Pharma KK develops, imports, produces and sells pharmaceutical products. The company was founded on April 1, 1997 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Tsukuba | College/University | Graduate Degree |
Statistiche
Distribuzione geografica
| Giappone | 11 |
| Taiwan | 2 |
| Corea del Sud | 2 |
| Cina | 2 |
| Germania | 2 |
Settori
| Health Technology | 7 |
| Consumer Services | 4 |
| Health Services | 2 |
| Finance | 2 |
| Process Industries | 2 |
Posizioni
| Director/Board Member | 32 |
| Independent Dir/Board Member | 9 |
| President | 8 |
| Corporate Officer/Principal | 7 |
| Chairman | 5 |
Contatti più connessi
- Borsa valori
- Insiders
- Keigo Tsujimoto
- Connessioni Società
